ABI1 can also inhibit EMT in prostate cancer by suppressing FYN-signal transducer and activator of transcription 3 (STAT3) activation by non-canonical WNT signaling through a high affinity interaction between the FYN SH2 domain and ABI1 pY421 [95]. Here, ABI1 is linked to prostate cancer.